For NCE development, at late discovery stage, the focus is to select the right (de-risked) candidate for development. Many multi-national pharmaceutical companies have a preclinical CMC group to provide support and guidance for candidate selection.  HLK strives to provide the same capabilities.

Our scientific team is experienced in providing such support:

Physicochemical characterizations

            Solubility and stability assessments

            pKa, LogP measurements

            Pre-formulation assessment

Formulation development for tox studies and pharmacology studies in animals

Tel: +86-755-86007001   Email: